LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced the grant of an inducement award to its newly appointed Chief Executive Officer, Anne Whitaker. The award was approved by the Board’s Compensation Committee and ratified by the full Board on August 1, 2014 as an inducement material to Ms. Whitaker’s entering into employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4). The award was approved subject to her commencement of employment with the Company on September 2, 2014.
Help employers find you! Check out all the jobs and post your resume.
